PerkinElmer’s €500m debut screeches tighter in secondary
PerkinElmer, the US human and environmental health technologies company, rolled into a piping hot European bond market on Tuesday and aggressively cut pricing on its debut euro bond, only for it to snap 35bp tighter in secondary.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article:
- ✔ 4,000 annual insights
- ✔ 700+ notes and long-form analyses
- ✔ 4 capital markets databases
- ✔ Daily newsletters across markets and asset classes
- ✔ 2 weekly podcasts